A newspaper hires an IRB

Credit: © ANDREI TCHERNOV" /> Credit: © ANDREI TCHERNOVIn June 2004, Erica Heath, who formerly ran the University of California, San Francisco's institutional review board (IRB), got an unusual call. Douglas Fischer, a reporter at the Oakland Tribune, told her he wanted to test the blood of four family members for levels of polybrominated diphenyl ether (PBDE) fire retardants, and publish the results in the paper. "She laughed when I told her what I wanted to do," says Fischer.

Written byIvan Oransky
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

In June 2004, Erica Heath, who formerly ran the University of California, San Francisco's institutional review board (IRB), got an unusual call. Douglas Fischer, a reporter at the Oakland Tribune, told her he wanted to test the blood of four family members for levels of polybrominated diphenyl ether (PBDE) fire retardants, and publish the results in the paper. "She laughed when I told her what I wanted to do," says Fischer. "Then she got quite serious."

Fischer became interested in the levels of PBDE fire retardants in the breast milk and blood of Californians after writing several stories about the work of Kim Hooper, a toxicologist at the California Environmental Protection Agency in nearby Berkeley who had found very high levels of the chemical in breast milk. Fischer says he "got a phenomenal response," mostly from women asking: "What's in me, where did it come from, and what's it doing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies